Vincerx Pharma, Inc. (VINC)
NASDAQ: VINC · Real-Time Price · USD
0.259
-0.017 (-6.04%)
Nov 21, 2024, 3:49 PM EST - Market open
Vincerx Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 2.94 | 12.78 | 11.66 | 111.46 | 61.79 | - |
Short-Term Investments | 7.14 | - | 40.8 | - | - | - |
Cash & Short-Term Investments | 10.09 | 12.78 | 52.46 | 111.46 | 61.79 | - |
Cash Growth | -51.51% | -75.63% | -52.93% | 80.38% | - | - |
Other Receivables | 1.06 | 1.29 | 1.37 | - | - | - |
Receivables | 1.06 | 1.29 | 1.37 | - | - | - |
Prepaid Expenses | 0.28 | 0.05 | 0.13 | 0.18 | 1.1 | - |
Restricted Cash | 0.09 | 0.07 | 0.07 | 0.11 | - | - |
Other Current Assets | 0.23 | 0.53 | 1.93 | 0.1 | 0.21 | - |
Total Current Assets | 11.75 | 14.73 | 55.96 | 111.84 | 63.11 | - |
Property, Plant & Equipment | 1.52 | 2.33 | 3.24 | 4.18 | - | - |
Other Long-Term Assets | 1.68 | 1.16 | 0.08 | 1.65 | 0.08 | - |
Total Assets | 14.95 | 18.22 | 59.29 | 117.68 | 63.19 | - |
Accounts Payable | 1.96 | 2.5 | 4.07 | 2.02 | 0.49 | 0.04 |
Accrued Expenses | 1.72 | 1.76 | 3.92 | 4.72 | 5 | - |
Current Portion of Leases | 1.27 | 1.16 | 1.02 | 0.74 | - | - |
Other Current Liabilities | 0.46 | 0.19 | 0.14 | 6.45 | 32.32 | 0.01 |
Total Current Liabilities | 5.42 | 5.61 | 9.16 | 13.92 | 37.81 | 0.04 |
Long-Term Leases | 0.37 | 1.34 | 2.41 | 3.44 | - | - |
Other Long-Term Liabilities | 0.05 | 0.05 | 0.05 | - | - | - |
Total Liabilities | 5.84 | 7 | 11.62 | 17.36 | 37.81 | 0.04 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 190.19 | 170.32 | 166.65 | 156.31 | 42.04 | 0 |
Retained Earnings | -181.19 | -159.11 | -118.96 | -55.97 | -16.67 | -0.05 |
Comprehensive Income & Other | 0.1 | 0.01 | -0.03 | -0.02 | - | -0 |
Shareholders' Equity | 9.11 | 11.22 | 47.67 | 100.32 | 25.38 | -0.04 |
Total Liabilities & Equity | 14.95 | 18.22 | 59.29 | 117.68 | 63.19 | - |
Total Debt | 1.64 | 2.5 | 3.44 | 4.17 | - | - |
Net Cash (Debt) | 8.45 | 10.28 | 49.02 | 107.29 | 61.79 | - |
Net Cash Growth | -53.17% | -79.03% | -54.31% | 73.62% | - | - |
Net Cash Per Share | 0.27 | 0.48 | 2.33 | 6.25 | 11.77 | - |
Filing Date Shares Outstanding | 33.56 | 21.41 | 21.25 | 21.06 | 13.98 | 9.33 |
Total Common Shares Outstanding | 21.41 | 21.41 | 21.24 | 21.06 | 13.98 | 9.33 |
Working Capital | 6.32 | 9.13 | 46.81 | 97.92 | 25.3 | -0.04 |
Book Value Per Share | 0.43 | 0.52 | 2.24 | 4.76 | 1.81 | -0.00 |
Tangible Book Value | 9.11 | 11.22 | 47.67 | 100.32 | 25.38 | -0.04 |
Tangible Book Value Per Share | 0.43 | 0.52 | 2.24 | 4.76 | 1.81 | -0.00 |
Machinery | - | 0.26 | 0.26 | 0.26 | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.